RecallRadar

FDA Drug recall D-1579-2014

PAXIL CR (Paroxetine HCL) Controlled-Release Tablets 37.5 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Man…

On 2014-09-10 the FDA classified a Class II recall of PAXIL CR (Paroxetine HCL) Controlled-Release Tablets 37.5 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Man… by Apotex, citing chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1579-2014
ClassificationClass II
Statusterminated
Initiated2014-03-24
Published2014-09-10
Last updated2026-09-13 11:51 UTC
CompanyApotex
DistributionUS

Product

PAXIL CR (Paroxetine HCL) Controlled-Release Tablets 37.5 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3670-3

Reason

Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.

Identifiers

ndc60505-4377-3
ndc60505-4378-3
ndc60505-4379-3
ndc60505-3668-3
ndc60505-3669-3
ndc60505-3670-3
code_infoLot # 2E001; Exp. 05/15

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1579-2014%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.